CHA2DS2-VASc score predicts contrast induced nephropathy in patients with ST-segment elevation myocardial infarction who were undergoing primary percutaneous coronary intervention
Event: ESC Congress 2018
Topic: Revascularisation
Session: Coronary artery disease: diagnosis, pharmacotherapy and revascularisation
